MetLife, Inc. $MET Shares Purchased by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn & Co. AG raised its stake in MetLife, Inc. (NYSE:METFree Report) by 16.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 73,525 shares of the financial services provider’s stock after purchasing an additional 10,229 shares during the quarter. B. Metzler seel. Sohn & Co. AG’s holdings in MetLife were worth $5,825,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in MET. Vermillion & White Wealth Management Group LLC boosted its holdings in shares of MetLife by 790.0% in the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 316 shares during the last quarter. Sound Income Strategies LLC boosted its holdings in shares of MetLife by 58.9% in the 4th quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 142 shares during the last quarter. Foster Dykema Cabot & Partners LLC acquired a new position in shares of MetLife in the 3rd quarter valued at $32,000. Albion Financial Group UT acquired a new position in shares of MetLife in the 4th quarter valued at $32,000. Finally, JPL Wealth Management LLC acquired a new position in shares of MetLife in the 3rd quarter valued at $33,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of MET stock opened at $76.07 on Friday. The company’s fifty day simple moving average is $73.09 and its 200-day simple moving average is $76.71. MetLife, Inc. has a 52 week low of $67.33 and a 52 week high of $83.85. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52. The company has a market cap of $49.60 billion, a PE ratio of 16.19, a P/E/G ratio of 0.68 and a beta of 0.74.

MetLife (NYSE:METGet Free Report) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, beating analysts’ consensus estimates of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business had revenue of $52.44 billion for the quarter, compared to the consensus estimate of $31.43 billion. During the same quarter last year, the firm posted $2.08 EPS. The business’s revenue for the quarter was up 27.6% compared to the same quarter last year. As a group, equities research analysts anticipate that MetLife, Inc. will post 9.85 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on MET shares. Bank of America decreased their price target on shares of MetLife from $103.00 to $99.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Weiss Ratings lowered shares of MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, March 9th. Barclays decreased their price target on shares of MetLife from $92.00 to $89.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. Evercore set a $96.00 price target on shares of MetLife in a report on Thursday, April 9th. Finally, Wall Street Zen raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Saturday, April 11th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $93.38.

Check Out Our Latest Stock Analysis on MET

About MetLife

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.